Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$549K Buy
4,034
+701
+21% +$92.4K 0.08% 65
2025
Q1
$442K Buy
3,333
+1,740
+109% +$221K 0.08% 73
2024
Q4
$180K Sell
1,593
-1,740
-52% -$201K 0.03% 82
2024
Q3
$380K Sell
3,333
-3,407
-51% -$374K 0.06% 86
2024
Q2
$700K Buy
6,740
+1,740
+35% +$184K 0.13% 63
2024
Q1
$568K Hold
5,000
0.16% 49
2023
Q4
$550K Buy
5,000
+4,936
+7,713% +$493K 0.24% 42
2023
Q3
$6.19K Hold
64
﹤0.01% 150
2023
Q2
$6.93K Buy
+64
New +$6.82K ﹤0.01% 154

Other funds holding ABT

Belmont Capital's ABT Position: Q2 2025 in Review

Belmont Capital increased its Abbott (ABT) stake by 21% in Q2 2025, buying an estimated $92.4K and bringing the position to 4,034 shares worth $549K. The position accounts for 0.08% of the portfolio, ranked #65.

Belmont Capital first reported a position in ABT in Q2 2023 and has held it in 9 quarters since. The position peaked at $700K in Q2 2024. 3,185 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Belmont Capital held 4,034 shares of Abbott worth $549K as of Q2 2025.
  • Belmont Capital bought 701 Abbott shares in Q2 2025, an estimated $92.4K.
  • Abbott made up 0.08% of Belmont Capital's portfolio in Q2 2025, its #65 holding.
  • Belmont Capital first reported a position in Abbott in Q2 2023 and has held it in 9 quarters since.
  • Belmont Capital's Abbott position peaked at $700K in Q2 2024.
  • 3,185 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Belmont Capital's 13F filing for Q2 2025, filed 12 Aug 2025.